Literature DB >> 13043342

[Experimental basis of chemotherapy of cancer].

H DRUCKREY.   

Abstract

Entities:  

Keywords:  NEOPLASMS/therapy

Mesh:

Year:  1952        PMID: 13043342     DOI: 10.1055/s-0028-1117290

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  8 in total

1.  [Results of radiobiological research in its significance for the treatment of skin tumors].

Authors:  W LORENZ
Journal:  Arch Klin Exp Dermatol       Date:  1957

2.  [Experimental basis of chemotherapy of cancer].

Authors:  H DRUCKREY
Journal:  Klin Wochenschr       Date:  1955-09-01

3.  [Experimental research on the effect of hormones on the Walker carcinoma in rats and on the development of benzopyrene tumors of the skin in mice].

Authors:  W DONTENWILL
Journal:  Z Krebsforsch       Date:  1955

4.  Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.

Authors:  W Schwarz; R W Hartmann; J Engel; M R Schneider; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  [Cell count and frequency of mitosis in development of carcinoma of the cervix (on carcinoma in situ and microcarcinoma)].

Authors:  H G Hillemanns; D Fröhlich; E Prestel
Journal:  Arch Gynakol       Date:  1968

6.  Ideas and reality in the development of cancer chemotherapeutic agents, with particular reference to oxazaphosphorine cytostatics.

Authors:  N Brock
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 7.  Cytochrome P450-activated prodrugs.

Authors:  Paul R Ortiz de Montellano
Journal:  Future Med Chem       Date:  2013-02       Impact factor: 3.808

8.  Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate.

Authors:  M R Schneider; E von Angerer; J Prekajac; W P Brade
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.